BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16849542)

  • 1. p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints.
    Wang S; El-Deiry WS
    Cancer Res; 2006 Jul; 66(14):6982-9. PubMed ID: 16849542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p73, a sophisticated p53 family member in the cancer world.
    Ozaki T; Nakagawara A
    Cancer Sci; 2005 Nov; 96(11):729-37. PubMed ID: 16271066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
    John K; Alla V; Meier C; Pützer BM
    Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
    Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
    Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible role of p73 on the modulation of p53 level through MDM2.
    Wang XQ; Ongkeko WM; Lau AW; Leung KM; Poon RY
    Cancer Res; 2001 Feb; 61(4):1598-603. PubMed ID: 11245471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p73 is transcriptionally regulated by DNA damage, p53, and p73.
    Chen X; Zheng Y; Zhu J; Jiang J; Wang J
    Oncogene; 2001 Feb; 20(6):769-74. PubMed ID: 11314010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.
    Stiewe T; Theseling CC; Pützer BM
    J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
    Marabese M; Vikhanskaya F; Rainelli C; Sakai T; Broggini M
    Nucleic Acids Res; 2003 Nov; 31(22):6624-32. PubMed ID: 14602923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73.
    Huang V; Lu X; Jiang Y; Wang JY
    BMC Biol; 2009 Jun; 7():35. PubMed ID: 19558638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.
    Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A
    Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest.
    Vossio S; Palescandolo E; Pediconi N; Moretti F; Balsano C; Levrero M; Costanzo A
    Oncogene; 2002 May; 21(23):3796-803. PubMed ID: 12032848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the interleukin 4 receptor alpha gene as a direct target for p73.
    Sasaki Y; Mita H; Toyota M; Ishida S; Morimoto I; Yamashita T; Tanaka T; Imai K; Nakamura Y; Tokino T
    Cancer Res; 2003 Dec; 63(23):8145-52. PubMed ID: 14678968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 tumor-suppressor activity is impaired in human thyroid cancer.
    Frasca F; Vella V; Aloisi A; Mandarino A; Mazzon E; Vigneri R; Vigneri P
    Cancer Res; 2003 Sep; 63(18):5829-37. PubMed ID: 14522906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
    Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
    Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of p73 and p53 regulation and effector functions.
    Fang L; Lee SW; Aaronson SA
    J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relief of p53-mediated telomerase suppression by p73.
    Toh WH; Kyo S; Sabapathy K
    J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73.
    Davis PK; Dowdy SF
    Int J Biochem Cell Biol; 2001 Oct; 33(10):935-9. PubMed ID: 11470228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes.
    Lefkimmiatis K; Caratozzolo MF; Merlo P; D'Erchia AM; Navarro B; Levrero M; Sbisa' E; Tullo A
    Cancer Res; 2009 Nov; 69(22):8563-71. PubMed ID: 19861536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of telomerase activity by the p53 family member p73.
    Beitzinger M; Oswald C; Beinoraviciute-Kellner R; Stiewe T
    Oncogene; 2006 Feb; 25(6):813-26. PubMed ID: 16205639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.
    Kartasheva NN; Contente A; Lenz-Stöppler C; Roth J; Dobbelstein M
    Oncogene; 2002 Jul; 21(31):4715-27. PubMed ID: 12101410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.